Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in Germany
2 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 4Not yet taking people in GermanyRituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
- Where
- Berlin
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07010302 - No phaseTaking peoplePerformance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- Where
- Dresden, Essen, Munich
- Age
- 18 years and over
- People
- 103 worldwide
- Run by
- Ad scientiam
See details and how to joinNCT05566769